Τρίτη, 19 Μαρτίου 2019

Atherosclerosis

E-cigarettes and Atherosclerotic Cardiovascular Disease: What Clinicians and Researchers Need to Know
Abstract Purpose of Review Electronic cigarettes, commonly known as electronic nicotine delivery systems (ENDS), e-cigarettes, or vapes, are growing in use and popularity. E-cigarettes are not one distinct type of product. These devices have evolved from the initial "cigarette-alike" designs to larger tank-style devices and most recently, smaller "mod-pods" that can be easily hidden. E-cigarettes can deliver nicotine at levels similar...
Latest Results for Current Atherosclerosis Reports
Sat Mar 16, 2019 02:00
Recent Updates on the Use of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease
Abstract Purpose of Review Atherosclerotic cardiovascular disease (ASCVD) is caused by elevated levels of low-density lipoprotein cholesterol (LDL-C). Although statins significantly reduce ASCVD risk, there remains a high degree of residual risk in statin-treated patients. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition has emerged as a significant therapeutic target for further lowering of LDL-C when used in combination...
Latest Results for Current Atherosclerosis Reports
Sat Mar 16, 2019 02:00
2018 Cholesterol Guidelines: Key Topics in Primary Prevention
Abstract Purpose of Review The 2018 American College of Cardiology (ACC) and American Heart Association (AHA) cholesterol guidelines are a comprehensive update providing recommendations for management of patients with high blood cholesterol based on the best available evidence. This review highlights key topics clinicians need to know for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) based on the 2018 ACC/AHA...
Latest Results for Current Atherosclerosis Reports
Sat Mar 16, 2019 02:00
Can Lp(a) Lowering Against Background Statin Therapy Really Reduce Cardiovascular Risk?
Abstract Purpose of Review The association between elevated plasma levels of lipoprotein (a) [Lp(a)] and atherosclerotic cardiovascular disease (ASCVD) has been discussed for many years. Recent genetic findings have confirmed that elevated Lp(a) similar to elevated LDL-cholesterol (LDL-C) might be causally related to premature ASCVD. Lp(a) is relatively refractory to lifestyle interventions. The results of studies with statins and...
Latest Results for Current Atherosclerosis Reports
Thu Mar 07, 2019 02:00
Alexandros Sfakianakis
Anapafseos 5 . Agios Nikolaos
Crete.Greece.72100
2841026182
6948891480

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις